| Patents for C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836) |
|---|
| 03/20/2001 | CA2211385C N-1-carboxyalkyl derivatives of lsd |
| 02/07/2001 | EP0830370B1 N-1-carboxyalkyl derivatives of lsd |
| 01/11/2001 | WO2001002395A1 Method for preparing lysergic acid |
| 08/17/2000 | WO2000047571A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation |
| 08/17/2000 | CA2362389A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation |
| 08/16/2000 | EP1027889A2 Ergolin derivates for transdermal application |
| 08/03/2000 | WO2000044748A1 Process for the preparation of alkyl mercapto methyl ergoline derivatives |
| 07/20/2000 | WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
| 07/12/2000 | CN1259946A Ergoline derivatives and their use as somatostatin receptor antagonists |
| 07/11/2000 | US6087371 Treating central nervous system disorders associated with serotoninergic disfunctions, such as impairment of thermoregulation, memory function, sleep disorders, satiety control (i.e. food and beverage consumption) |
| 06/02/2000 | WO2000030644A1 Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline |
| 06/02/2000 | WO2000030643A1 Novel therapeutic application of nicergoline |
| 05/16/2000 | US6063908 Reagents for lysergic acid diethylamide immunoassay |
| 05/09/2000 | US6060483 Ergoline derivatives |
| 03/22/2000 | EP0986558A2 Ergoline derivatives and their use as somatostatin receptor antagonists |
| 01/27/2000 | WO2000004018A1 Ergoline amine derivatives with blood pressure lowering effect |
| 01/27/2000 | DE19832191A1 New N-acylated ergoline amine derivatives, are alpha-1 adrenoreceptor blockers useful as potent, well tolerated antihypertensive agents |
| 01/27/2000 | CA2337881A1 Novel ergoline amine derivatives and their use |
| 08/26/1999 | WO1999042840A1 Immunoassays for determination of lsd and lsd metabolites |
| 06/02/1999 | EP0593692B1 Process for the preparation of ergoline derivatives |
| 05/26/1999 | EP0917874A1 Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates |
| 05/05/1999 | CN1043230C Serotoninergic ergoline derivs. |
| 04/14/1999 | EP0907651A1 Antineurodegenerative ergoline derivatives |
| 03/17/1999 | CN1211253A Heterocyclyl-ergoline derivatives as 5-HT1A receptor ligands |
| 03/04/1999 | WO1998054183A3 Ergoline derivatives and their use as somatostatin receptor antagonists |
| 02/02/1999 | US5866584 Administration of a dopamine agonist, over a limited period at a time of day dependent on the normal circadian rhythm of insulin resistant and insulin sensitive members of a similar species. |
| 12/29/1998 | US5854255 Therapeutic package for the long term reduction of body fat stores insulin resistance hyperinsulinemia and hyperglycemia in vertebrates |
| 12/23/1998 | EP0885222A1 Heterocyclyl-ergoline derivatives as 5-ht1a receptor ligands |
| 12/03/1998 | WO1998054183A2 Ergoline derivatives and their use as somatostatin receptor antagonists |
| 12/03/1998 | CA2288810A1 Ergoline derivatives and their use as somatostatin receptor antagonists |
| 12/01/1998 | US5843682 N-1-carboxyalkyl derivatives of LSD |
| 10/28/1998 | CN1040438C One-pot process for preparing sulfur propyl ergoline |
| 07/08/1998 | CN1186663A Process for preparing pharmaceutical formulation containing ergoline-8-carboxamides derivatives |
| 07/01/1998 | CN1038937C Preparation of ergoline-8-carboxamides |
| 05/27/1998 | CN1038510C Process for the synthesis of ergoline derivatives |
| 05/12/1998 | US5750519 Administering dopamine antagonist and prolactin stimulator |
| 04/14/1998 | US5739146 Substituted cyclo or bicycloalkylamides of (8β)-6-(substituted) ergolines |
| 03/25/1998 | EP0830370A1 N-1-carboxyalkyl derivatives of lsd |
| 03/24/1998 | US5731312 Administering mixture of dopamine antagonist and prolactin inhibitor |
| 02/17/1998 | US5719160 Method for modifying and regulating lipid metabolism |
| 02/10/1998 | US5716957 Administering a hypoglycemic agent or dopaminergic agent once a day and within two hours after waking in morning |
| 02/10/1998 | CA1339661C Cycloalkylamides of (8b)-1alkyl-6 (substituted)ergolines |
| 01/08/1998 | WO1998000424A1 Antineurodegenerative ergoline derivatives |
| 01/08/1998 | CA2258627A1 Antineurodegenerative ergoline derivatives |
| 01/07/1998 | EP0816364A1 Reagents for lysergic acid diethylamide immunoassay |
| 12/16/1997 | CA1339584C 2-substituted ergolines, their production and use |
| 11/11/1997 | CA1339533C T-butyl ergoline derivatives |
| 09/30/1997 | CA2019407C Stereoselective hydrogenation process |
| 08/21/1997 | WO1997030050A1 Heterocyclyl-ergoline derivatives as 5-ht1a receptor ligands |
| 08/21/1997 | CA2243992A1 Heterocyclyl-ergoline derivatives as 5-ht1a receptor ligands |
| 08/05/1997 | US5654313 Administering a prolactin-inhibiting compound and subsequently a prolactin-stimulating compound |
| 07/30/1997 | EP0515537B1 Substituted urea compounds and their preparation and use |
| 06/03/1997 | US5635512 Method for modifying or resetting the prolactin rhythm of an insulin insensitive or diabetic animal or human |
| 05/29/1997 | WO1997019100A1 N-1-carboxyalkyl derivatives of lsd |
| 05/20/1997 | CA2112355C Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
| 01/15/1997 | EP0427827B1 8-alpha-ACYLAMINO-ERGOLINES, THEIR PREPARATION AND USE AS DRUGS |
| 12/24/1996 | CA2030174C Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates |
| 10/23/1996 | CN1134158A N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions contg. these compounds |
| 09/10/1996 | US5554623 Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates |
| 08/21/1996 | EP0726909A1 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds |
| 08/20/1996 | US5547958 Parkinson's disease |
| 03/05/1996 | US5496803 Administering prolactin by itself or with a glucosteroid such as cortisol |
| 01/30/1996 | CA2001004C Antiemesis ergoline derivatives |
| 01/02/1996 | US5480885 Ergoline derivatives of 1-propinylamine, a process for the manufacture thereof and the use thereof for medicaments |
| 12/06/1995 | EP0464178B1 Process for preparing ergoline derivatives |
| 11/09/1995 | WO1995029912A1 Ergoline derivatives as analgesics |
| 10/31/1995 | US5463060 One-pot process |
| 08/15/1995 | US5441961 Substituted cyclo or bicycloalkylamides of (8β)-6-(substituted) ergolines |
| 07/12/1995 | EP0463139B1 2,13-disubstituted ergolins, their preparation and their use in drugs |
| 07/04/1995 | US5430031 Serotoninergic ergoline derivatives |
| 05/11/1995 | WO1995012610A1 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds |
| 05/11/1995 | CA2173844A1 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds |
| 05/02/1995 | US5411966 2, 13-disubstituted ergolines, their production and use in pharmaceutical agents |
| 03/30/1995 | DE4333287A1 Fluorinated ergolines |
| 03/28/1995 | US5401748 2,14-disubstituted ergolines, their production and use in pharmaceutical compositions |
| 03/21/1995 | US5399355 Uniform penetration through skin |
| 01/17/1995 | US5382669 Process for the preparation of ergoline derivatives |
| 12/14/1994 | EP0628042A1 Serotoninergic ergoline derivatives |
| 12/06/1994 | US5371000 Process for the production of ergoline derivatives |
| 10/05/1994 | CN1093087A Serotoninergic ergoline derivatives |
| 09/06/1994 | US5344832 Administering dopamine agonist and prolactin stimulator |
| 08/02/1994 | US5334385 New alkaloid derivatives, their use and pharmaceutical formulations containing them |
| 07/07/1994 | WO1994014806A1 Serotoninergic ergoline derivatives |
| 04/27/1994 | EP0593692A1 Process for the preparation of ergoline derivatives |
| 04/13/1994 | EP0591458A1 Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
| 03/01/1994 | US5290795 Substituted urea compound and use |
| 02/23/1994 | CN1082544A One-pot process |
| 02/22/1994 | US5288724 Antiserotonine agents, hypotensive agents, antidepressants |
| 02/15/1994 | EP0591458A4 Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates. |
| 12/08/1993 | EP0573260A1 New alkaloid derivatives, their use and pharmaceutical formulations containing them |
| 12/08/1993 | CN1023014C Process for preparing ergoline derivatives |
| 11/24/1993 | EP0571202A1 One-pot process for preparing pergolide |
| 10/06/1993 | EP0564193A1 Heteroannulation process |
| 10/04/1993 | CA2092782A1 Heteroannulation process |
| 09/16/1993 | WO1993018034A1 Process for the preparation of ergoline derivatives |
| 09/15/1993 | CN1076196A Process for the synthesis of ergoline derivatives |
| 09/07/1993 | US5242678 BR*-diagnostics for monoamine receptors |
| 06/30/1993 | EP0548327A1 2,14-disubstituted ergolines, their production and use in medicaments |
| 06/29/1993 | CA1319684C Ergolinyl compounds nitrogen-substituted in the 8- position, their preparation, and use as medicinal agents |